Moody 's Investors Service Inc said may upgrade rating Upjohn Co 's 400 mln dlrs debt .
The agency said study effect new product may Upjohn 's earnings potential .
Moody 's also ass effect growth broader diversification pharmaceutical cash flow operating performance .
Moody 's noted pharmaceutical health-care market characterized greater stability cash flow .
Upjohn currently carry Aa-3 senior unsecured long-term debt industrial revenue bond .
The company 's Prime-1 commercial paper review .
Reuter & # 3 ; 